Hair Restoration for Women — Causes and Solutions

Last updated: 5 March 2026

Female hair loss affects approximately 40% of women by age 50, yet it remains significantly less discussed than male pattern baldness. The psychological impact can be profound, as hair is deeply connected to feminine identity and self-esteem in most cultures. Understanding the diverse causes of female hair loss and evidence-based treatment options enables effective management and restoration of confidence.

Understanding Female Hair Loss Patterns

Unlike male pattern baldness, which typically presents with receding hairline and crown thinning, female hair loss more commonly manifests as diffuse thinning across the entire scalp, particularly concentrated at the central part. Complete baldness is rare in women, but progressive reduction in hair density and diameter creates visible scalp show-through that causes significant distress.

The Hair Growth Cycle:

Understanding normal hair biology illuminates why disruptions cause loss. Hair follicles cycle through three phases: anagen (active growth phase lasting 2-7 years), catagen (transitional phase lasting 2-3 weeks), and telogen (resting phase lasting 2-4 months before hair sheds). Approximately 85-90% of scalp hairs are in anagen at any time, with 10-15% in telogen. Normal shedding is 50-100 hairs daily. When this balance shifts—more hairs entering telogen or shortened anagen phase—noticeable thinning occurs.

Common Causes of Female Hair Loss

Androgenetic Alopecia (Female Pattern Hair Loss):

The most common cause, affecting up to 50% of women during their lifetime, androgenetic alopecia results from genetic susceptibility and hormonal influences. Dihydrotestosterone (DHT)—a metabolite of testosterone—miniaturises susceptible hair follicles, progressively reducing hair diameter and shortening the growth phase. Unlike men, women typically maintain the frontal hairline whilst experiencing diffuse central thinning graded using the Ludwig or Savin scales.

Risk factors include family history, hormonal changes (menopause, PCOS), and ageing. Clinical diagnosis is confirmed through history, examination, and sometimes scalp biopsy or trichoscopy.

Telogen Effluvium:

This reactive hair loss occurs when physical or emotional stressors shift large numbers of follicles prematurely into telogen phase. Triggers include childbirth (postpartum hair loss, typically 3-6 months after delivery), significant weight loss or nutritional deficiency, major surgery or serious illness, medications (beta-blockers, anticoagulants, antidepressants), and severe psychological stress.

Shedding typically begins 2-3 months after the triggering event and can persist for 6 months, though regrowth usually occurs once the trigger resolves. Chronic telogen effluvium lasting beyond 6 months requires thorough evaluation for underlying conditions.

Hormonal Imbalances:

Thyroid disorders (both hyperthyroidism and hypothyroidism) disrupt the hair cycle, causing diffuse thinning. Polycystic ovary syndrome (PCOS) increases androgens, potentially causing both scalp hair loss and unwanted facial hair growth. Menopause-related oestrogen decline unmasks androgenic effects on follicles. Iron deficiency and anaemia impair follicle function even without causing systemic symptoms.

Autoimmune and Inflammatory Conditions:

Alopecia areata causes patchy, non-scarring hair loss through autoimmune attack on follicles. It can progress to total scalp loss (alopecia totalis) or complete body hair loss (alopecia universalis). Scarring alopecias including lichen planopilaris and frontal fibrosing alopecia permanently destroy follicles, requiring early diagnosis and aggressive treatment to prevent progression.

Traction Alopecia and Styling Damage:

Chronic tension from tight hairstyles (braids, ponytails, extensions, weaves) damages follicles, particularly along the frontal and temporal hairline. Chemical treatments, heat styling, and mechanical damage weaken hair shafts, causing breakage. Early intervention can allow recovery, but prolonged traction causes permanent scarring.

Diagnostic Evaluation: Finding the Cause

Effective treatment requires accurate diagnosis. Comprehensive evaluation includes detailed history assessing onset pattern, triggers, medical conditions, medications, diet, and family history. Physical examination evaluates hair distribution, scalp condition, and signs of other androgen effects. Laboratory testing may include full blood count (anaemia), ferritin (iron stores), thyroid function tests, hormonal panel (testosterone, DHEAS for PCOS), and vitamin D and B12 levels.

Specialised tests including trichoscopy (dermoscopic scalp examination), hair pull test (assessing active shedding), and scalp biopsy (for unclear or scarring alopecia) may be warranted.

Evidence-Based Treatment Options

Topical Minoxidil:

The only FDA-approved topical treatment for female pattern hair loss, minoxidil 2% or 5% solution/foam applied twice daily stimulates follicles, prolongs anagen phase, and increases hair diameter. Clinical trials demonstrate that 40-60% of women experience noticeable improvement after 6-12 months of consistent use. Treatment must continue indefinitely to maintain results—discontinuation leads to shedding of newly grown hair within 3-4 months.

Side effects include scalp irritation, unwanted facial hair growth (particularly with 5% formulation), and initial increased shedding during the first 6-8 weeks as follicles synchronise.

Anti-Androgenic Medications:

Spironolactone, an aldosterone antagonist with anti-androgenic properties, reduces DHT effects on follicles. Prescribed off-label for female pattern hair loss at doses of 50-200mg daily, it stabilises hair loss and promotes regrowth in many patients. Requires reliable contraception due to anti-androgenic effects on male foetus. Regular monitoring of blood pressure and potassium levels is necessary.

Combined oral contraceptives with low androgenic potential can help women with PCOS or hormonal hair loss by regulating hormones and reducing free testosterone.

Platelet-Rich Plasma (PRP):

PRP injections deliver concentrated growth factors to the scalp, stimulating follicle activity and hair growth. A systematic review in Aesthetic Plastic Surgery found significant improvements in hair density and thickness following a series of 3-4 monthly treatments. Maintenance sessions every 4-6 months sustain results. PRP works particularly well when combined with minoxidil or other treatments.

Low-Level Laser Therapy (LLLT):

FDA-cleared devices delivering specific wavelengths (630-670nm) of red light stimulate follicles through photobiomodulation, increasing cellular energy production and promoting hair growth. Home-use devices include laser caps, helmets, and combs used for 20-30 minutes several times weekly. Clinical evidence shows modest improvements in hair density and thickness with consistent use over 6-12 months.

Hair Transplantation:

Follicular unit extraction (FUE) or follicular unit transplantation (FUT) can restore density in women with stable pattern hair loss and adequate donor area. Female hair transplantation requires different planning than male procedures due to diffuse thinning pattern rather than discrete bald areas. Candidacy depends on having sufficient donor density, realistic expectations, and stable underlying cause.

Nutritional Supplementation:

Correcting deficiencies is essential: iron supplementation for low ferritin (target >70ng/mL for optimal hair growth), vitamin D if deficient, and biotin, though evidence for biotin in non-deficient individuals is weak despite popularity. Marine collagen and specific nutrient blends show some promise in clinical trials but require further research.

Addressing Underlying Causes

For secondary hair loss, treating the underlying condition is paramount. Thyroid optimisation through appropriate medication, PCOS management through lifestyle modification and/or metformin/anti-androgens, stress reduction through psychological support and lifestyle changes, and nutritional rehabilitation for eating disorders or deficiencies all play critical roles.

Cosmetic Solutions and Psychological Support

While pursuing medical treatment, cosmetic approaches help maintain confidence including volumising styling techniques and products, hair fibres and sprays that camouflage thinning, partial hairpieces or toppers for coverage, and high-quality wigs for significant loss.

Psychological impact should not be underestimated. Support groups, counselling, and connection with others experiencing hair loss provide valuable emotional support during treatment.

Key Takeaways

• Female hair loss has multiple causes requiring accurate diagnosis for effective treatment
• Androgenetic alopecia is most common but telogen effluvium and hormonal factors are frequent
• Minoxidil and anti-androgens have the strongest evidence for female pattern hair loss
• PRP and LLLT offer promising adjunctive treatments with good safety profiles
• Combination approaches addressing multiple factors often deliver optimal results

Medical Disclaimer: This article provides educational information only and does not constitute medical advice. Hair loss requires professional evaluation to determine underlying causes and appropriate treatment. Self-diagnosis and treatment can delay proper care and worsen outcomes. Medications discussed have contraindications and side effects requiring medical supervision. Individual results vary based on hair loss type, severity, and patient factors. Consult a dermatologist or trichologist for comprehensive evaluation and personalised treatment planning.